You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

SaltaCord Theraputics Cancer Program

CanCells : Genetic Predisposition Cancer Screening

Personal Genomics is the next major medical program paradign, allowing doctors to user genetic information to choose the most ideal drugs/treatment to help curing patients. We will help you discover if you are genetically predisposed to one or several cancers:

Basal cell carcinoma
Bladder Cancer
Breast Cancer
Chronic Lymphocytic
Colorectal Cancer
Follicular Lymphoma
Hodkin's Lymphoma
Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cell Carcinoma
Thyroid Cancer
Testicular Cancer

NK TEST : NK Cell Functional Activating Profiling

This flow cytometry based test is intended to investigate altered NK function found in various disorders and to evaluate the effects of drugs on NK activity. A depression of NK cell activity is usually observed in patients with advanced cancer and with metastatic disease. Depression of NK cell activity is observed in patients with preleukemia, acute or chronic leukemia. NK cell cytotoxic activity is of prognostic value for the probablity of developing metastasis in patients with primary tumors. NK cell activity can now be proven in an objective and reproducible manner with this test.

Hematopoietic Stem Cell(HSCs) Based Services

Design and training for low cost BMT units, Bone Marrow Stem Cell(BM-HSC) Transplantations, PB MNCs, T-Cell depletions, Haploidentical Transplants, MUD, Cord Blood HSCs, Bone marrow preservation banking, HLA matching and search at BM registries.

Donor Lymphocyte Infusions : Graft versus Malignancy

Giving chemotherapy/ total-body irradiation before a donor peripheral blood stem cell transplant helps stop and growth of cancer and abnormal cells and helps stop the patient's immune system from rejecting the donor's stem cells. When stem cells from a donor are infused into the patient body, they may help the patient's bone marrow make stem cells, red blood cells , white blood cells, and platelets. Sometimes the transplanted cells from a donor can make an immune response against the body's normal cells. Removing/depleting the T-Cells from the donor cells before transplant may stop this from happening. Giving and infusion of the donor's T-Cells(Donor lymphocyte infusion) after transplant may help destroy any remaining cancer cells(graft-versus-tumor effect).

Adoptive T-Cell Therapies

Adoptive T-Cell therapy involves the isolation and ex vivo expansion of tumor specific T-Cells to achieve greater number of T-Cells that what could be obtained by vaccination alone.The tumor specific T-Cells are then infused into patients with cancer in an attempt to give the immune system, the ability to overwhelm remaining tumor via T-Cells which an attack and kill cancer. There are many forms of adoptive T-Cells therapy being used for cancer treatment; culturing tumor infiltration lymphocytes or TIL, isolating and expanding one particular T-Cell or clone, even using T-Cells that have been engineered to potently recognize and attack tumors.

Activation of PB-MNCs

SaltaCord has found out molecules which work at the nano and picogram quantities to activate the Peripheral Blood Mononuclear Cells(PB-MNCs).Some of these molecules are classified as biological, new age homeopathic drugs, and also some as - traditional herbal medicines. In vitro exposure of the patients PB-MNCs to these molecules followed by their administration IV has shown reduction in tumor sizes and cured 1st relapse patients - disease free.

Immunotherapy with Biologicals

SaltaCord has been able to develop some very effective treatment protocols using immunodulatory cytokines, groeth factors, immunoglobulins, small molecules, vitamin binding proteins and homeopathic approaches. These molecules and preparations are known to module the immune system, and have shown encouraging results in various end stage cancer patients including renal cell carcinomas.

Genetic & Cellular Chemo Sensitivity Prediction

We use a personalized approach to predict best prescription options for chemo therapies to our partner doctors. This is done by genetic analysis of the tumor biopsy and also by high throughput screening of anticancer drugs against the patient's cancer cells.

One Step Gel Separation Technology